BioScrip (NASDAQ: BIOS) is to float a 12.5 million-strong offering of its common stock in an underwritten public offering. That amount includes 3.125 million shares being offered by selling stockholders. The price has been set at $12.00 per share. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 1.875 million shares.

BioScrip estimates it will reap proceeds of roughly $106.5 million, and will use the monies for "general corporate purposes." It will not take in any proceeds from the shares offered by the selling stockholders.

Leucadia's Jefferies, Morgan Stanley, and SunTrust's Robinson Humphrey unit are the joint book-running managers of the issue.

Fool contributor Eric Volkman has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.